Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

References for PMC Articles for PubMed (Select 11179298)

1.

Studies in shigellosis. III. A controlled evaluation of a monovalent Shigella vaccine in a highly endemic environment.

HIGGINS AR, FLOYD TM, KADER MA.

Am J Trop Med Hyg. 1955 Mar;4(2):281-8. No abstract available.

PMID:
14361907
3.

Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM.

Bull World Health Organ. 1999;77(8):651-66.

4.

Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice.

Pavliakova D, Chu C, Bystricky S, Tolson NW, Shiloach J, Kaufman JB, Bryla DA, Robbins JB, Schneerson R.

Infect Immun. 1999 Oct;67(10):5526-9.

5.

Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.

Ashkenazi S, Passwell JH, Harlev E, Miron D, Dagan R, Farzan N, Ramon R, Majadly F, Bryla DA, Karpas AB, Robbins JB, Schneerson R.

J Infect Dis. 1999 Jun;179(6):1565-8.

7.

Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers.

Gupta RK, Taylor DN, Bryla DA, Robbins JB, Szu SC.

Infect Immun. 1998 Jul;66(7):3095-9.

8.
9.

Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.

Cohen D, Ashkenazi S, Green MS, Gdalevich M, Robin G, Slepon R, Yavzori M, Orr N, Block C, Ashkenazi I, Shemer J, Taylor DN, Hale TL, Sadoff JC, Pavliakova D, Schneerson R, Robbins JB.

Lancet. 1997 Jan 18;349(9046):155-9.

PMID:
9111538
10.

Existing status of shigellosis in Andaman & Nicobar islands.

Ghosh AR, Sehgal SC.

Indian J Med Res. 1996 Mar;103:134-7.

PMID:
9062037
11.

Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers.

Cohen D, Ashkenazi S, Green M, Lerman Y, Slepon R, Robin G, Orr N, Taylor DN, Sadoff JC, Chu C, Shiloach J, Schneerson R, Robbins JB.

Infect Immun. 1996 Oct;64(10):4074-7.

14.

Shigella lipopolysaccharide antibodies in pediatric populations.

Passwell JH, Freier S, Shor R, Farzam N, Block C, Lison M, Shiff E, Ashkenazi S.

Pediatr Infect Dis J. 1995 Oct;14(10):859-65.

PMID:
8584312
15.

Relationship between humoral immune responses and oral temperature during human shigellosis.

Mackowiak PA, Wasserman SS, Levine MM.

J Infect Dis. 1993 Jun;167(6):1449-52.

PMID:
8501337
17.
18.
19.

Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation.

Schwendeman SP, Costantino HR, Gupta RK, Siber GR, Klibanov AM, Langer R.

Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11234-8.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk